Recent

% | $
Quotes you view appear here for quick access.

Biogen Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • mishamagosh mishamagosh May 18, 2005 8:39 AM Flag

    Which is better...?

    I posted this yesterday but it seemed to have disappeared and hour later.

    DNA executives at BIIB is not a new thing. They may be considering using Oceanside to produce more Rituxan for its ever increasing uses. BGEN had been working with DNA before it became BIIB on another class of immunosuppressives that may be getting closer to cllinical trials and need to produce drug for that--BIIB would benifit as does DNA. Maybe they were looking the place over but it doesn't mean a buy out--but then again it could.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
BIIB
419.44-9.21(-2.15%)Apr 17 4:00 PMEDT